13 batches were not tested.

The notice shows that a total of 12 production enterprises (preparation units) marked a total of 11 varieties of 13 batches of drugs, after sampling does not meet the standard requirements, of which 10 varieties are Chinese medicine tablets: licorice, orange, yellow cypress, ginger half summer, lotus heart, former Hu, fist ginseng, meat tablets, mulberry parasitic, five plus skin.
non-conforming items: content determination, moisture, traits, leaching, total ash, identification - microscopic characteristics The original text is as follows: In order to strengthen drug quality supervision, to ensure the safety of public drug use, according to the annual sampling work plan of the provincial drug regulatory bureau, the provincial bureau of drugs The production, operation and use units have carried out spot checks and inspections on the quality of medicines, and the situation of non-compliant drugs found in the spot checks is heeded as follows: First, after verification and confirmation, 11 varieties of 12 production enterprises (preparation units) marked a total of 13 batches of drugs, after sampling does not meet the standards.
2. The relevant drug regulatory department has taken control measures such as seizure, seizure, suspension of sales and product recall of non-compliant products, and shall, in accordance with relevant laws and regulations, seriously investigate and punish the relevant production enterprises (preparation units) and sampled units in accordance with the law, and may inquire about the website of the relevant municipal market supervision authority.
, for non-compliant products and corresponding production and operation enterprises and units, the relevant drug regulatory departments should strengthen supervision, urge them to identify the causes of the problems, formulate and implement corrective measures, and effectively eliminate hidden risks.
he hedes this notice.
Drug Administration, Shandong Province, September 17, 2020.